Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Asset Allocation median (36 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 50 history starts 18 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Quant Multi Asset Allocation Fund |
|---|---|
| 03 Apr 2006 | ₹100.00 |
| 14 Dec 2007 | ₹106.87 |
| 26 Aug 2009 | ₹141.85 |
| 08 May 2011 | ₹152.44 |
| 17 Jan 2013 | ₹171.34 |
| 30 Sep 2014 | ₹192.09 |
| 11 Jun 2016 | ₹218.70 |
| 21 Feb 2018 | ₹239.87 |
| 04 Nov 2019 | ₹283.51 |
| 16 Jul 2021 | ₹508.78 |
| 28 Mar 2023 | ₹580.89 |
| 08 Dec 2024 | ₹974.22 |
| 20 Aug 2026 | ₹1182.73 |
| Metric | quant · Regular NAV ₹168.97 High risk ★★★☆☆ | Category median Multi Asset Allocation · 36 funds |
|---|---|---|
| +19.02% | +13.66% | |
| +21.74% | +15.55% | |
| +19.27% | +13.48% | |
| +17.96% | +11.02% | |
| +12.89% | +12.56% | |
| +18.77% | — | |
| +13.53% | +14.34% | |
| +13.01% | +11.77% | |
| +11.61% | +10.03% | |
| Risk | ||
| 11.42% | 10.32% | |
| 1.33 | 0.81 | |
| 1.89 | 1.11 | |
| -32.58% | -12.33% | |
| Nifty 50 | — | |
| +12.62% | +7.29% | |
| 0.63 | 0.62 | |
| 98.2% | 83.8% | |
| 11.5% | 24.4% | |
| 2.28% | 2.15% | |
| ₹5,474Cr | ₹2,048Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| 0% | 53% | |
| Sanjeev Sharma | — | |
| 03 Apr 2006 | — | |
| 24 | — | |
| 53.0% | — | |
| 10.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.